Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
Ichimura Y, Asano Y, Hatano M, Tamaki Z, Takekoshi T, Kogure A, Tomita M, Kawashima T, Miyazaki M, Taniguchi T, Takahashi T, Mitsui H, Sugaya M, Yao A, Kinugawa K, Sato S. Ichimura Y, et al. Mod Rheumatol. 2011 Oct;21(5):548-52. doi: 10.1007/s10165-011-0436-5. Epub 2011 Mar 10. Mod Rheumatol. 2011. PMID: 21547701
Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases.
Takahashi T, Asano Y, Amiya E, Hatano M, Tamaki Z, Ozeki A, Watanabe A, Kawarasaki S, Nakao T, Taniguchi T, Ichimura Y, Toyama T, Watanabe M, Hirata Y, Nagai R, Sato S. Takahashi T, et al. Among authors: ichimura y. Mod Rheumatol. 2012 Aug;22(4):598-601. doi: 10.1007/s10165-011-0545-1. Epub 2011 Oct 21. Mod Rheumatol. 2012. PMID: 22015621
Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis.
Masui Y, Asano Y, Takahashi T, Shibata S, Akamata K, Aozasa N, Noda S, Taniguchi T, Ichimura Y, Toyama T, Tamaki Z, Sumida H, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T. Masui Y, et al. Among authors: ichimura y. Mod Rheumatol. 2013 Mar;23(2):323-9. doi: 10.1007/s10165-012-0660-7. Epub 2012 May 19. Mod Rheumatol. 2013. PMID: 22610787
Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis.
Takahashi T, Asano Y, Akamata K, Aozasa N, Taniguchi T, Noda S, Masui Y, Ichimura Y, Toyama T, Tamaki Z, Tada Y, Sugaya M, Kadono T, Sato S. Takahashi T, et al. Among authors: ichimura y. Mod Rheumatol. 2013 Sep;23(5):884-90. doi: 10.1007/s10165-012-0755-1. Epub 2012 Sep 13. Mod Rheumatol. 2013. PMID: 22972016
Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis.
Yanaba K, Asano Y, Noda S, Akamata K, Aozasa N, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Tada Y, Sugaya M, Kadono T, Sato S. Yanaba K, et al. Among authors: ichimura y. Clin Rheumatol. 2013 Jan;32(1):43-7. doi: 10.1007/s10067-012-2089-y. Epub 2012 Sep 16. Clin Rheumatol. 2013. PMID: 22983266
Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
Noda S, Asano Y, Aozasa N, Akamata K, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S. Noda S, et al. Among authors: ichimura y. Arch Dermatol Res. 2013 May;305(4):325-31. doi: 10.1007/s00403-012-1307-4. Epub 2012 Dec 12. Arch Dermatol Res. 2013. PMID: 23233281
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
Noda S, Asano Y, Takahashi T, Akamata K, Aozasa N, Taniguchi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S. Noda S, et al. Among authors: ichimura y. Rheumatology (Oxford). 2013 May;52(5):790-9. doi: 10.1093/rheumatology/kes379. Epub 2013 Jan 3. Rheumatology (Oxford). 2013. PMID: 23287360
229 results